1451 / 1816
Re-staging of the breast: ongoing studies
breast surgery, an expected average of 4 months. ]
Two studies comparing biopsy findings with final pathology findings
NRG Oncology study,
USA, NCT03188393:
•
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to
Determine if Patients Can Avoid Breast Surgery
•
N = 175, between 2017 – 2019:
•
Stereotactic biopsy any time before BCS.
MICRA
study, Netherlands, NTR 6120
•
Minimally Invasive Complete Response Assessment of the breast after
primary systemic treatment
•
N = 440, between 2016-2019.
•
8 biopsies immediately prior to surgery; 4 at <0.5 cm distance of
the marker; 4 at 1.0-1.5 cm distance of the marker.